Sharapova's Positive Drug Test Just Cost Her Almost $300,000
- Tennis rules say athletes caught doping forfeit prize money
- The No. 7 woman lost in the Australian Open quarterfinals
Maria Sharpova Fails Drug Test, What's Next?
This article is for subscribers only.
Maria Sharapova failed a drug test at the Australian Open, a result that could cost the tennis player a spot at the Rio 2016 Olympics and the $298,000 she won in January at the Australian Open.
One of the best female tennis players of her generation, Sharapova said at a news conference Monday that she had been taking meldonium for health reasons for a decade and had not noticed when it was banned by the World Anti-Doping Agency as of Jan. 1.